Lung function decline in COPD trials

European Respiratory Journal

Volumn 33, Issue 3, 2009, Pages 708-709

  Keene, O N ^a   Celli, B ^e   Anderson, J A ^a   Ferguson, G T ^f   Jenkins, C R ^g   Jones, P W ^b   Vestbo, J ^c   Knobil, K ^a   Yates, J C ^a   Calverley, P M A ^d  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^e ST ELIZABETH'S MEDICAL CENTER   (United States)

^f Pulmonary Research Institute of Southeast Michigan   (United States)

^g Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; PLACEBO; SALMETEROL;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG FUNCTION; PRIORITY JOURNAL; RANDOM SAMPLE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

BIAS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; HUMANS; LUNG; PLACEBOS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 61649119324     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00169908     Document Type: Letter

References (9)

1. Suissa S. Lung function decline in COPD trials: bias from regression to the mean. Eur Respir J 2008; 32: 829-831.
2. Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
3. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332-338.
4. Tashkin DP, Celli BR, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary diease. N Engl J Med 2008; 359: 1543-1554.
5. Aaron SD, Vandemheen KL, Fergusson D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007; 146: 545-555.
6. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005; 34: 215-220.
7. Molenberghs G, Thijs H, Jansen I, et al. Analyzing incomplete longitudinal clinical trial data. Biostatistics 2004; 5: 445-464.
8. Decramer M, Molenberghs G. Does pharmacotherapy reduce the rate of decline of lung function in COPD? Am J Respir Crit Care Med 2009; 179: 171.
9. Celli B. Does pharmacotherapy reduce the rate of decline of lung function in COPD? Am J Respir Crit Care Med 2009; 179: 171-172.